Improving Memory in Patients With Multiple Sclerosis
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
|Official Title:||Interventions to Improve Memory in Patients With Multiple Sclerosis|
|Study Start Date:||September 1999|
|Estimated Study Completion Date:||August 2002|
Cognitive dysfunction is one of the leading causes of disability in people with MS. Memory involving specific words (verbal memory) is particularly affected in individuals with MS. Attempts to rehabilitate cognitive dysfunction in MS have had only limited success.
This study will determine the efficacy of donepezil therapy and glucose administration for enhancing verbal memory functioning in individuals with MS. The study will also measure secondary outcomes assessing other areas of cognitive dysfunction (i.e., nonverbal memory, conceptual thinking, processing speed) which may improve with intervention.
Forty participants with MS will be randomly assigned to receive either donepezil or placebo for 24 weeks. Participants will complete memory and cognitive tests at the beginning and end of the 24 week period.
Twenty participants with MS will be randomly assigned to drink a beverage sweetened with either glucose or saccharin (placebo). Participants will then complete memory and other cognitive tests. Two weeks later, participants will drink a beverage sweetened with the alternative sweetener and again complete the memory and cognitive tests.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00062972
|United States, New York|
|University Hospital and Medical Center|
|Stony Brook, New York, United States, 11794-8121|
|Principal Investigator:||Lauren B. Krupp, MD||Department of Neurology, University Hospital Medical Center|